• 24 Citations
  • 4 h-Index
20172018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Ramona Rotolo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Cytokine-Induced Killer Cells Medicine & Life Sciences
Neoplastic Stem Cells Medicine & Life Sciences
Sarcoma Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Antigen Receptors Medicine & Life Sciences
Mitogen-Activated Protein Kinase Kinases Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2018

  • 24 Citations
  • 4 h-Index
  • 4 Article
4 Citations (Scopus)

BRAF and MEK inhibitors increase PD-1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti–PD-1 antibody

Sanlorenzo, M., Vujic, I., Floris, A., Novelli, M., Gammaitoni, L., Giraudo, L., Macagno, M., Leuci, V., Rotolo, R., Donini, C., Basirico, M., Quaglino, P., Fierro, M. T., Giordano, S., Sibilia, M., Carnevale-Schianca, F., Aglietta, M. & Sangiolo, D., Jul 15 2018, In : Clinical Cancer Research. 24, 14, p. 3377-3385 9 p.

Research output: Contribution to journalArticle

Mitogen-Activated Protein Kinase Kinases
Melanoma
Lymphocytes
Antibodies
Recurrence
4 Citations (Scopus)

CD44v6 as innovative sarcoma target for CAR-redirected CIK cells

Leuci, V., Casucci, G. M., Grignani, G., Rotolo, R., Rossotti, U., Vigna, E., Gammaitoni, L., Mesiano, G., Fiorino, E., Donini, C., Pisacane, A., ambrosio, L. D., Pignochino, Y., Aglietta, M., Bondanza, A. & Sangiolo, D., May 4 2018, In : OncoImmunology. 7, 5, e1423167.

Research output: Contribution to journalArticle

Cytokine-Induced Killer Cells
Antigen Receptors
Sarcoma
Heterografts
Neoplasms
4 Citations (Scopus)

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.

Mesiano, G., Grignani, G., Fiorino, E., Leuci, V., Rotolo, R., D’Ambrosio, L., Salfi, C., Gammaitoni, L., Giraudo, L., Pisacane, A., Butera, S., Pignochino, Y., Basiricó, M., Capozzi, F., Sapino, A., Aglietta, M. & Sangiolo, D., Nov 2 2018, In : OncoImmunology. 7, 11, e1465161.

Research output: Contribution to journalArticle

Cytokine-Induced Killer Cells
Neoplastic Stem Cells
Sarcoma
Drug Therapy
Molecular Targeted Therapy
12 Citations (Scopus)

Cytokine-induced killer cells kill chemo-surviving melanoma cancer stem cells

Gammaitoni, L., Giraudo, L., MacAgno, M., Leuci, V., Mesiano, G., Rotolo, R., Sassi, F., Sanlorenzo, M., Zaccagna, A., Pisacane, A., Senetta, R., Cangemi, M., Cattaneo, G., Martin, V., Coha, V., Gallo, S., Pignochino, Y., Sapino, A., Grignani, G., Carnevale-Schianca, F. & 2 others, Aglietta, M. & Sangiolo, D., May 1 2017, In : Clinical Cancer Research. 23, 9, p. 2277-2288 12 p.

Research output: Contribution to journalArticle

Cytokine-Induced Killer Cells
Neoplastic Stem Cells
Melanoma
Drug Therapy
fotemustine